'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA Chief says

FDA Commissioner Scott Gottlieb said the U.S. has a "wacky" system where discounts on drug prices don't flow to patients paying for drugs. Rebates are a favorite target of pharmaceutical companies, who say pharmaceutical benefit managers extract huge discounts but keep them for themselves instead of sharing the savings with patients.